Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
59.85
+2.16 (3.74%)
At close: Jul 17, 2026, 4:00 PM EDT
60.90
+1.05 (1.75%)
After-hours: Jul 17, 2026, 5:14 PM EDT
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 370 employees as of December 31, 2025. The number of employees increased by 47 or 14.55% compared to the previous year.
Employees
370
Change (1Y)
47
Growth (1Y)
14.55%
Revenue / Employee
$1,446,159
Profits / Employee
-$130,446
Market Cap
2.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 370 | 47 | 14.55% |
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Nurix Therapeutics | 317 |
| Biohaven | 274 |
| Immunome | 206 |
| Pharvaris | 134 |
| Mesoblast | 81 |
| Mineralys Therapeutics | 76 |
TARS News
- 4 days ago - Tarsus Pharmaceuticals chief commercial officer Aziz Mottiwala to depart - TheFly
- 4 days ago - Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth - GlobeNewsWire
- 9 days ago - Tarsus Pharmaceuticals Transcript: M&A announcement - Transcripts
- 9 days ago - Tarsus Pharmaceuticals Press release: M&A announcement - Filings
- 9 days ago - Tarsus Pharmaceuticals Slides: M&A announcement - Filings
- 9 days ago - Tarsus Pharmaceuticals acquires iRenix Medical - TheFly
- 9 days ago - Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101 - GlobeNewsWire
- 9 days ago - Tarsus Pharmaceuticals Slides: Corporate presentation - Filings